ITP KIM Interventional Cannulas and BIM Biopsy Needles

Score breakdown

The products address a specific workflow gap by enabling procedures to be performed directly within the MRI suite rather than requiring separate procedural rooms. Features like preset depth stoppers, 10mm interval markings, and locking hubs support procedural efficiency. The range of configurations (multiple lengths and gauges) allows clinical teams to select appropriate devices for specific procedures rather than adapting workflows around limited options.

The source material contains no peer-reviewed citations, published studies, or quantitative data supporting clinical claims. While MRI-compatibility and artifact reduction are mentioned as design features, no technical specifications (e.g., susceptibility artifact measurements, signal-to-noise ratio data) or comparative studies are provided. External search confirms MRI-guided interventions are established ([imgsol.com](https://www.imgsol.com/precision-where-it-matters-most-biopsy-tools-for-mri-guided-interventions/)) but provides no independent validation of these specific products.

No clinical outcomes data, patient series, complication rates, or diagnostic accuracy metrics are provided in the source. The listed applications (spinal therapy, sympathicolysis, arthrography) represent known MRI-guided procedures, but no evidence is presented demonstrating this product's performance in those settings. Search results confirm the product exists but contain no independent clinical validation or comparative efficacy data.

The source contains no pricing information, cost comparisons, health economic analysis, or data on procedure time savings. Single-use format is mentioned but without cost implications. No information is provided on potential revenue generation from expanded MRI-guided procedural services or cost-effectiveness compared to alternative guidance modalities or competing MRI-compatible needles.

While MRI-compatible needles are not novel as a category, the integrated design features (adjustable depth stopper, locking stylet cap, coordinated KIM-BIM system) and breadth of configurations (30-200mm, 13G-25G) represent thoughtful product development. However, the source provides no competitive analysis or claims of proprietary technology that would distinguish these products from other MRI-compatible interventional devices on the market.

Patient: Patients potentially benefit from MRI's radiation-free imaging and superior soft-tissue visualization for targeting lesions. The ability to perform procedures within the MRI suite may reduce transfers between rooms. However, without data on complication rates, pain scores, or procedural success rates, the actual patient benefit of these specific devices versus alternatives cannot be quantified from the source. Clinician: Clinicians gain procedural flexibility with a range of needle configurations suited to different anatomies and depths. Features like depth presets and clear markings support procedural control. The coordinated cannula-biopsy needle system may simplify device selection. However, the source lacks data on learning curves, procedure times, or operator satisfaction that would substantiate workflow benefits in practice.

See Methodology for what each category measures and how the tier is computed.